Skip to main content

Peer Review reports

From: Interpreting drug synergy in breast cancer with deep learning using target-protein inhibition profiles

Original Submission
8 Aug 2023 Submitted Original manuscript
14 Aug 2023 Reviewed Reviewer Report - Jannis Born
18 Aug 2023 Reviewed Reviewer Report
22 Aug 2023 Reviewed Reviewer Report - Othman Soufan
26 Aug 2023 Reviewed Reviewer Report
29 Aug 2023 Reviewed Reviewer Report
4 Nov 2023 Author responded Author comments - Teeraphan Laomettachit
18 Dec 2023 Reviewed Reviewer Report
18 Dec 2023 Reviewed Reviewer Report - Jannis Born
25 Dec 2023 Reviewed Reviewer Report
1 Jan 2024 Author responded Author comments - Teeraphan Laomettachit
Resubmission - Version 2
4 Nov 2023 Submitted Manuscript version 2
4 Jan 2024 Reviewed Reviewer Report - Jannis Born
9 Jan 2024 Reviewed Reviewer Report
20 Feb 2024 Author responded Author comments - Teeraphan Laomettachit
Resubmission - Version 3
20 Feb 2024 Submitted Manuscript version 3
23 Feb 2024 Reviewed Reviewer Report - Jannis Born
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
23 Feb 2024 Editorially accepted
29 Feb 2024 Article published 10.1186/s13040-024-00359-z

You can find further information about peer review here.

Back to article page